| 000 | 01735 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515161600.0 | ||
| 264 | 0 | _c20090910 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1539-2031 | ||
| 024 | 7 |
_a10.1097/MCG.0b013e318184a470 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHass, Holger G | |
| 245 | 0 | 0 |
_aThyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1). _h[electronic resource] |
| 260 |
_bJournal of clinical gastroenterology _c |
||
| 300 |
_a470-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xetiology |
| 650 | 0 | 4 |
_aInterferon Type I _xadministration & dosage |
| 650 | 0 | 4 | _aInterferon-alpha |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aThyroid Diseases _xchemically induced |
| 650 | 0 | 4 |
_aThyroid Gland _ximmunology |
| 650 | 0 | 4 |
_aThyroiditis _xetiology |
| 650 | 0 | 4 |
_aThyrotropin _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aKlein, Reinhild | |
| 700 | 1 | _aNehls, Oliver | |
| 700 | 1 | _aKaiser, Stephan | |
| 773 | 0 |
_tJournal of clinical gastroenterology _gvol. 43 _gno. 5 _gp. 470-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MCG.0b013e318184a470 _zAvailable from publisher's website |
| 999 |
_c18688700 _d18688700 |
||